World Health Organization. (1992). The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: WHO.
[2]
American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Arlington, VA: American Psychiatric Publishing.
[3]
Goldberg, D., & Lecrubier, Y. (1995). Form and frequency of mental disorders across centres. In Üstün TB, Sartorius N (Eds.), Mental Illness in General Health Care: An International Study (pp. 323-334). Chichester: John Wiley & Sons.
[4]
Fava, G.A., & Sonino, N. (2008). The clinical aftermath of the modern era of neurasthenia. Psychotherapy and Psychosomatics, 77(5), 279-282.
[5]
Kirmayer, L.J. (2001). Cultural variations in the clinical presentation of depression and anxiety: Implications for diagnosis and treatment. Journal of Clinical Psychiatry, 62(Suppl 13), 22-30.
[6]
Kroenke, K., & Price, R.K. (1993). Symptoms in the community: Prevalence, classification, and psychiatric comorbidity. Archives of Internal Medicine, 153(21), 2474-2480.
[7]
Stewart, D.E. (1990). The changing faces of neurasthenia. Canadian Journal of Psychiatry, 35(4), 325-329.
[8]
Wessely, S., Nimnuan, C., & Sharpe, M. (1999). Functional somatic syndromes: One or many? Lancet, 354(9182), 936-939.
[9]
Zhang, M.Y. (1990). The diagnosis and frequency of neurasthenia in China. Chinese Journal of Psychiatry, 23, 17-20.
[10]
Katon, W., & Walker, E.A. (1998). Medically unexplained symptoms in primary care. Journal of Clinical Psychiatry, 59(Suppl 20), 15-21.